Home › Funds › ANTIPODES PARTNERS Ltd › ETR
ANTIPODES PARTNERS Ltd position in ETR
ENTERGY CORP NEW · Utilities
ANTIPODES PARTNERS Ltd reported holding 1,134,000 shares of ETR (ENTERGY CORP NEW) in its Q3 2026 13F filing — a position valued at US$112.6M, representing 2.08% of its reported portfolio and ranking #19 among its reported holdings. ANTIPODES PARTNERS Ltd has disclosed ETR holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ANTIPODES PARTNERS Ltd's ETR position evolved
ANTIPODES PARTNERS Ltd first disclosed a stake in ETR in Q3 2025 at 1,158,886 shares (US$108.0M). The position peaked in Q1 2026 at 1,162,738 shares, worth US$130.6M. Across 5 filings, ANTIPODES PARTNERS Ltd increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,134,000 shares valued at US$112.6M — an increase of 48,402 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.16M | $108.00M | New |
| Q4 2025 | 1.13M | $104.65M | Reduce |
| Q1 2026 | 1.16M | $130.65M | Add |
| Q2 2026 | 1.09M | $124.69M | Reduce |
| Q3 2026 | 1.13M | $112.56M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETR and 13F data
ETR (ENTERGY CORP NEW) is a Utilities company. 37 other funds we track also report a position in ETR — the largest reported positions include AMERIPRISE FINANCIAL INC (US$1.62B), Clearbridge Investments, LLC (US$695.8M), Boston Partners (US$679.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETR
- AMERIPRISE FINANCIAL INC 14.08M sh · $1.62B · Q2 2026
- Clearbridge Investments, LLC 7.01M sh · $695.75M · Q3 2026
- Boston Partners 6.83M sh · $679.61M · Q3 2026
- BARCLAYS PLC 5.28M sh · $524.11M · Q3 2026
- Newport Trust Company, LLC 5.06M sh · $501.88M · Q3 2026
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 5.06M sh · $501.82M · Q3 2026
- COHEN & STEERS, INC. 3.53M sh · $405.06M · Q2 2026
- Alkeon Capital Management 3.34M sh · $383.75M · Q2 2026
- REAVES W H & CO INC 2.91M sh · $288.72M · Q3 2026
- Citigroup Inc 2.72M sh · $269.74M · Q3 2026
More on ANTIPODES PARTNERS Ltd
FAQ
How long has ANTIPODES PARTNERS Ltd held ETR?
ANTIPODES PARTNERS Ltd has disclosed ETR holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is ANTIPODES PARTNERS Ltd's current position in ETR?
As of Q3 2026, ANTIPODES PARTNERS Ltd holds 1.13M shares of ETR (ENTERGY CORP NEW), valued at $112.56M, representing 2.08% of its reported portfolio and ranking #19.
Has ANTIPODES PARTNERS Ltd been buying or selling ETR?
In the latest 13F filing (Q3 2026), ANTIPODES PARTNERS Ltd increased its position in ETR. The position peaked in Q1 2026 at 1.16M shares.
Which other funds hold ETR?
Other major institutional holders of ETR include AMERIPRISE FINANCIAL INC, Clearbridge Investments, LLC, Boston Partners, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.